Bayer's response to the powerful and groundbreaking documentary, The Bleeding Edge, shows how little the company cares about the thousands of women injured by its unsafe products. From Yaz to Mirena to Essure, Bayer continues to prove it would be better served getting out of birth control business.
Bayer announces it will cease sales of Essure in the United States and Essure survivors everywhere celebrate their long-fought victory.
Recent new developments concerning the Essure Sterilization Device have occurred since January of this year. This article shows just how far the E-Sisters have come in their fight against Essure.
Effective July 1, 2018, Connecticut's Department of Social Services will no longer be covering sterilization with the Essure device under the Healthcare Common Procedure Coding System (HCPCS). It is anticipated that other states across the country will follow Connecticut's progressive lead and refuse to cover the costs of implanting the controversial sterilization device.
The damaging effects of gadolinium retention in the body have recently been the subject of world-wide research and recent studies reveal the dangers of this common used contrast agent in MRI scans nationwide.
Members of the Essure Problems Facebook Group are prominently featured in the acclaimed documentary, The Bleeding Edge. Don't miss free pre-release screenings of this powerful documentary to be released world-wide on Netflix on July 27, 2018
Bayer's Motions to Dismiss Plaintiffs' complaint for lack of personal jurisdiction was denied by not one, but two separate judges in Illinois recently, allowing the claims of nearly 200 Essure plaintiffs to move forward.
The powerful and impactful documentary by Kirby Dick, Amy Ziering and Amy Herdy exposes the lax approval process of medical devices in an industry where profits are prioritized over patients. Essure Problems advocates traveled to New York for the film premiere which exposes the medical device industry and the complicit FDA.
Yesterday the FDA announced it would restrict the sale and distribution of Essure to protect women and ensure that patients receive risk information. However, the welcome regulatory action goes much further.
In the last few month, Essure lawsuits have risen significantly from 10,600 to over 16,000. Women should seek counsel as their time to file a claim may be expiring soon.
